Cite
c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model.
MLA
Konno, Takumi, et al. “C-Jun N-Terminal Kinase Inhibitor SP600125 Enhances Barrier Function and Elongation of Human Pancreatic Cancer Cell Line HPAC in a Ca-Switch Model.” Histochemistry and Cell Biology, vol. 143, no. 5, May 2015, pp. 471–79. EBSCOhost, https://doi.org/10.1007/s00418-014-1300-4.
APA
Konno, T., Ninomiya, T., Kohno, T., Kikuchi, S., Sawada, N., & Kojima, T. (2015). c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model. Histochemistry and Cell Biology, 143(5), 471–479. https://doi.org/10.1007/s00418-014-1300-4
Chicago
Konno, Takumi, Takafumi Ninomiya, Takayuki Kohno, Shin Kikuchi, Norimasa Sawada, and Takashi Kojima. 2015. “C-Jun N-Terminal Kinase Inhibitor SP600125 Enhances Barrier Function and Elongation of Human Pancreatic Cancer Cell Line HPAC in a Ca-Switch Model.” Histochemistry and Cell Biology 143 (5): 471–79. doi:10.1007/s00418-014-1300-4.